Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H1WT
|
|||
| Drug Name |
Anti-SARS-CoV-2 REGN-COV2 vaccine
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Investigative | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Regeneron begins first clinical trials of anti-viral antibody cocktail regn-cov2 for the treatment and prevention of COVID-19. June 11, 2020. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.